FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3003313635> ?p ?o ?g. }

• W3003313635 endingPage "1866" @default.
• W3003313635 startingPage "1855" @default.
• W3003313635 abstract "Objective Efforts to manage non-alcoholic fatty liver disease (NAFLD) are limited by the incomplete understanding of the pathogenic mechanisms and the absence of accurate non-invasive biomarkers. The aim of this study was to identify novel NAFLD therapeutic targets andbiomarkers by conducting liver transcriptomic analysis in patients stratified by the presence of the PNPLA3 I148M genetic risk variant. Design We sequenced the hepatic transcriptome of 125 obese individuals. ‘Severe NAFLD’ was defined as the presence of steatohepatitis, NAFLD activity score ≥4 or fibrosis stage ≥2. The circulating levels of the most upregulated transcript, interleukin-32 (IL32), were measured by ELISA. Results Carriage of the PNPLA3 I148M variant correlated with the two major components of hepatic transcriptome variability and broadly influenced gene expression. In patients with severe NAFLD, there was an upregulation of inflammatory and lipid metabolism pathways. IL32 was the most robustly upregulated gene in the severe NAFLD group (adjusted p=1×10 −6 ), and its expression correlated with steatosis severity, both in I148M variant carriers and non-carriers. In 77 severely obese, and in a replication cohort of 160 individuals evaluated at the hepatology service, circulating IL32 levels were associated with both NAFLD and severe NAFLD independently of aminotransferases (p<0.01 for both). A linear combination of IL32-ALT-AST showed a better performance than ALT-AST alone in NAFLD diagnosis (area under the curve=0.92 vs 0.81, p=5×10 −5 ). Conclusion Hepatic IL32 is overexpressed in NAFLD, correlates with hepatic fat and liver damage, and is detectable in the circulation, where it is independently associated with the presence and severity of NAFLD." @default.
• W3003313635 created "2020-02-07" @default.
• W3003313635 creator A5012145852 @default.
• W3003313635 creator A5020610956 @default.
• W3003313635 creator A5024750114 @default.
• W3003313635 creator A5037216844 @default.
• W3003313635 creator A5039770438 @default.
• W3003313635 creator A5043738976 @default.
• W3003313635 creator A5046105984 @default.
• W3003313635 creator A5046751635 @default.
• W3003313635 creator A5048054475 @default.
• W3003313635 creator A5049517101 @default.
• W3003313635 creator A5050497878 @default.
• W3003313635 creator A5054402082 @default.
• W3003313635 creator A5070641717 @default.
• W3003313635 creator A5075397773 @default.
• W3003313635 creator A5081259222 @default.
• W3003313635 creator A5085631682 @default.
• W3003313635 creator A5091506479 @default.
• W3003313635 date "2020-01-30" @default.
• W3003313635 modified "2023-10-15" @default.
• W3003313635 title "Liver transcriptomics highlights interleukin-32 as novel NAFLD-related cytokine and candidate biomarker" @default.
• W3003313635 cites W1598102702 @default.
• W3003313635 cites W1606178710 @default.
• W3003313635 cites W1913897324 @default.
• W3003313635 cites W1979443397 @default.
• W3003313635 cites W1991575096 @default.
• W3003313635 cites W1993260392 @default.
• W3003313635 cites W1999574084 @default.
• W3003313635 cites W2017511982 @default.
• W3003313635 cites W2027846112 @default.
• W3003313635 cites W2030379010 @default.
• W3003313635 cites W2031119940 @default.
• W3003313635 cites W2043928284 @default.
• W3003313635 cites W2057521072 @default.
• W3003313635 cites W2067067743 @default.
• W3003313635 cites W2067740038 @default.
• W3003313635 cites W2083192581 @default.
• W3003313635 cites W2088567659 @default.
• W3003313635 cites W2096694584 @default.
• W3003313635 cites W2100573537 @default.
• W3003313635 cites W2127066789 @default.
• W3003313635 cites W2130410032 @default.
• W3003313635 cites W2137516998 @default.
• W3003313635 cites W2157826151 @default.
• W3003313635 cites W2167478342 @default.
• W3003313635 cites W2169456326 @default.
• W3003313635 cites W2179438025 @default.
• W3003313635 cites W2204688218 @default.
• W3003313635 cites W2214074259 @default.
• W3003313635 cites W2259938310 @default.
• W3003313635 cites W2333834718 @default.
• W3003313635 cites W2413052899 @default.
• W3003313635 cites W2518680640 @default.
• W3003313635 cites W2531040022 @default.
• W3003313635 cites W2554140915 @default.
• W3003313635 cites W2571018111 @default.
• W3003313635 cites W2588239649 @default.
• W3003313635 cites W2607779679 @default.
• W3003313635 cites W2616037908 @default.
• W3003313635 cites W2731411640 @default.
• W3003313635 cites W2736162169 @default.
• W3003313635 cites W2767801219 @default.
• W3003313635 cites W2963171665 @default.
• W3003313635 cites W4230266413 @default.
• W3003313635 doi "https://doi.org/10.1136/gutjnl-2019-319226" @default.
• W3003313635 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7497582" @default.
• W3003313635 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32001554" @default.
• W3003313635 hasPublicationYear "2020" @default.
• W3003313635 type Work @default.
• W3003313635 sameAs 3003313635 @default.
• W3003313635 citedByCount "64" @default.
• W3003313635 countsByYear W30033136352020 @default.
• W3003313635 countsByYear W30033136352021 @default.
• W3003313635 countsByYear W30033136352022 @default.
• W3003313635 countsByYear W30033136352023 @default.
• W3003313635 crossrefType "journal-article" @default.
• W3003313635 hasAuthorship W3003313635A5012145852 @default.
• W3003313635 hasAuthorship W3003313635A5020610956 @default.
• W3003313635 hasAuthorship W3003313635A5024750114 @default.
• W3003313635 hasAuthorship W3003313635A5037216844 @default.
• W3003313635 hasAuthorship W3003313635A5039770438 @default.
• W3003313635 hasAuthorship W3003313635A5043738976 @default.
• W3003313635 hasAuthorship W3003313635A5046105984 @default.
• W3003313635 hasAuthorship W3003313635A5046751635 @default.
• W3003313635 hasAuthorship W3003313635A5048054475 @default.
• W3003313635 hasAuthorship W3003313635A5049517101 @default.
• W3003313635 hasAuthorship W3003313635A5050497878 @default.
• W3003313635 hasAuthorship W3003313635A5054402082 @default.
• W3003313635 hasAuthorship W3003313635A5070641717 @default.
• W3003313635 hasAuthorship W3003313635A5075397773 @default.
• W3003313635 hasAuthorship W3003313635A5081259222 @default.
• W3003313635 hasAuthorship W3003313635A5085631682 @default.
• W3003313635 hasAuthorship W3003313635A5091506479 @default.
• W3003313635 hasBestOaLocation W30033136351 @default.
• W3003313635 hasConcept C104317684 @default.
• W3003313635 hasConcept C126322002 @default.
• W3003313635 hasConcept C127561419 @default.

• next